Sabra Healthcare REIT (NASDAQ:SBRA) Price Target Raised to $22.00 at Truist Financial

Sabra Healthcare REIT (NASDAQ:SBRA) had its target price raised by Truist Financial from $21.00 to $22.00 in a research note issued to investors on Friday morning,Benzinga reports. They currently have a hold rating on the real estate investment trust’s stock.

A number of other research analysts also recently issued reports on SBRA. Cantor Fitzgerald boosted their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 17th. Weiss Ratings reiterated a “buy (b)” rating on shares of Sabra Healthcare REIT in a research report on Thursday, January 22nd. UBS Group lifted their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a research note on Thursday, February 19th. Citigroup boosted their target price on shares of Sabra Healthcare REIT from $21.00 to $24.00 and gave the company a “buy” rating in a report on Wednesday, February 18th. Finally, Jefferies Financial Group reiterated a “buy” rating and set a $22.00 price target on shares of Sabra Healthcare REIT in a report on Monday, December 15th. Five research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $21.90.

Sabra Healthcare REIT Trading Down 0.8%

Shares of SBRA stock opened at $20.62 on Friday. The stock has a market cap of $5.20 billion, a price-to-earnings ratio of 32.22, a PEG ratio of 1.67 and a beta of 0.64. The stock has a 50-day moving average of $19.65 and a 200-day moving average of $19.01. The company has a current ratio of 4.29, a quick ratio of 4.29 and a debt-to-equity ratio of 0.90. Sabra Healthcare REIT has a 1-year low of $15.75 and a 1-year high of $21.07.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings data on Thursday, February 12th. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.26). The company had revenue of $201.35 million during the quarter, compared to analyst estimates of $201.97 million. Sabra Healthcare REIT had a return on equity of 5.63% and a net margin of 20.09%.Sabra Healthcare REIT’s revenue was up 16.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, equities research analysts forecast that Sabra Healthcare REIT will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 27th. Stockholders of record on Friday, February 13th were given a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, February 13th. This represents a $1.20 annualized dividend and a dividend yield of 5.8%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 187.50%.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of SBRA. Corient Private Wealth LLC acquired a new stake in Sabra Healthcare REIT in the fourth quarter worth $266,000. Hsbc Holdings PLC raised its holdings in shares of Sabra Healthcare REIT by 19.7% during the fourth quarter. Hsbc Holdings PLC now owns 514,409 shares of the real estate investment trust’s stock valued at $9,738,000 after purchasing an additional 84,784 shares during the period. Beaird Harris Wealth Management LLC acquired a new position in shares of Sabra Healthcare REIT during the fourth quarter valued at about $114,000. Mercer Global Advisors Inc. ADV boosted its position in shares of Sabra Healthcare REIT by 14.4% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 66,869 shares of the real estate investment trust’s stock worth $1,267,000 after purchasing an additional 8,411 shares in the last quarter. Finally, EP Wealth Advisors LLC bought a new position in shares of Sabra Healthcare REIT during the 4th quarter worth about $300,000. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.